Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
8.52
0.00 (0.00%)
At close: Aug 20, 2025, 3:59 PM
8.52
0.00%
After-hours: Aug 20, 2025, 05:43 PM EDT
Y-mAbs Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -22.22M | -28.23M | -29.67M | -23.86M | -24.61M | -21.67M | -21.43M | -19.28M | -39.06M | -73.89M | -95.57M | -133.62M | -134.95M | -116.76M | -55.27M | -38.31M | -42.29M | -59.74M |
Depreciation & Amortization | 347K | 447K | 535K | 594K | 641K | 712K | 735K | 804K | 862K | 826K | 839K | 900K | 819K | 847K | 782K | 608K | 556K | 440K |
Stock-Based Compensation | 13.52M | 14.05M | 14.56M | 14.6M | 12.9M | 13.08M | 14.54M | 14.95M | 15.8M | 25.82M | 25.6M | 26.97M | 28.53M | 19.73M | 19.33M | 22.76M | 21M | 18.62M |
Other Working Capital | -19.18M | 1.58M | 5.89M | -7.57M | 18.07M | -6.02M | -4.59M | -5.98M | -9.31M | -147K | -3.44M | 521K | -306K | -1.42M | 1.76M | 6.12M | 10.09M | 7.97M |
Other Non-Cash Items | -3.39M | -1.22M | 82K | -437K | 3.44M | 1.84M | 889K | -1.68M | 16K | 2.81M | 3.58M | 4.84M | 3.12M | 1.77M | -60.55M | -62.21M | -62.44M | -53.9M |
Deferred Income Tax | n/a | n/a | n/a | -3.33M | -3.33M | -2.28M | -2.28M | 1.05M | 1.05M | n/a | n/a | n/a | n/a | n/a | 435K | 435K | 435K | 435K |
Change in Working Capital | -6.04M | -4.19M | -1.22M | -9.44M | -1.59M | -9.27M | -19.69M | -23.71M | -24.42M | -19.68M | -10.37M | -222K | 2.52M | -1.21M | -7.28M | -9.67M | -9.71M | -7.18M |
Operating Cash Flow | -17.8M | -19.15M | -15.71M | -21.88M | -12.55M | -17.59M | -27.23M | -27.86M | -45.75M | -64.12M | -75.92M | -101.12M | -99.96M | -95.62M | -102.56M | -86.39M | -92.46M | -101.34M |
Capital Expenditures | -127K | -127K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -455K | -526K | -567K | -967K | -556K | -588K | -549K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -300K | -300K | -300K | 61.71M | 62.01M | 59.4M | 59.4M |
Investing Cash Flow | -127K | -127K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -455K | -526K | -567K | 61.04M | 61.45M | 58.81M | 58.85M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52K | 52K | 84K | 184K | 380K | 511K | 589K | 1.91M | 1.88M | 1.74M |
Financial Cash Flow | 2.41M | 3.84M | 4.31M | 3.42M | 2.45M | 688K | 100K | n/a | 52K | 52K | 84K | 184K | 380K | 511K | 108.31M | 109.63M | 109.6M | 109.47M |
Net Cash Flow | -15.51M | -15.44M | -11.4M | -18.45M | -10.1M | -16.88M | -27.13M | -27.95M | -45.76M | -64.09M | -75.8M | -101.2M | -99.92M | -95.55M | 66.93M | 84.46M | 75.53M | 66.5M |
Free Cash Flow | -17.92M | -19.27M | -15.71M | -21.88M | -12.55M | -17.59M | -27.23M | -27.86M | -45.75M | -64.12M | -75.92M | -101.58M | -100.49M | -96.19M | -103.52M | -86.94M | -93.05M | -101.89M |